Showing results (2151-2160 of 2,378) with videos related to

Sort By:
Pageof 238
Nature|October 7, 2021
Hemispheric black carbon increase after the 13th-century Māori arrival in New ZealandJoseph R McConnell, Nathan J Chellman, Robert Mulvaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Phase I dose-escalation trial of the oral investigational Hedgehog signaling pathway inhibitor TAK-441 in patients with advanced solid tumorsJonathan Goldman, S Gail Eckhardt, Mitesh J Borad, et al.
Investigational New Drugs|December 31, 2015
Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancersElizabeth R Kessler, S Gail Eckhardt, Todd M Pitts, et al.
The Oncologist|June 9, 2017
A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRASChristopher H Lieu, Manuel Hidalgo, Jordan D Berlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignanciesMiguel A Villalona-Calero, S Gail Eckhardt, Geoffrey Weiss, et al.
Frontiers in Immunology|May 16, 2022
Diagnostic Value of a Protocolized In-Depth Evaluation of Pediatric Bone Marrow Failure: A Multi-Center Prospective Cohort StudyKhaled Atmar, Claudia A L Ruivenkamp, Louise Hooimeijer, et al.
BMJ Open|December 28, 2020
Global impact of tobacco control policies on smokeless tobacco use: a systematic review protocolMonika Arora, Aastha Chugh, Neha Jain, et al.
Molecular Cancer Therapeutics|November 29, 2018
Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type MelanomaLenka Sinik, Katherine A Minson, John J Tentler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2011
Preclinical activity of the rational combination of selumetinib (AZD6244) in combination with vorinostat in KRAS-mutant colorectal cancer modelsM Pia Morelli, John J Tentler, Gillian N Kulikowski, et al.
Plos Genetics|July 1, 2016
Super Resolution Fluorescence Microscopy and Tracking of Bacterial Flotillin (Reggie) Paralogs Provide Evidence for Defined-Sized Protein Microdomains within the Bacterial Membrane but Absence of Clusters Containing Detergent-Resistant ProteinsFelix Dempwolff, Felix K Schmidt, Ana B Hervás, et al.
Pageof 238